Delivery Order SPE2DB20D1100-SPE2DB24FA7H2
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $1,052.14 to supply Testosterone Cypionate 200 mg/ml. The contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,769.12 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of testosterone cypionate 200 mg/mL medical injections. This order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of testosterone cypionate at $4,380.42. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,018.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical sourcing and distribution company. The contract is for the delivery of testosterone cypionate 200 mg/mL medication to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product called Testosterone CYP 200 mg/mL. The award, valued at $2,090.59, has a completion date of February 13, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and this order is issued under an Indefinite Delivery Contract (IDC) with DLA valued at up...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of testosterone cypionate 200 mg/mL. The contract has a ceiling value of $1,368.00 and a period of performance through April 4, 2024. This delivery order is placed under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp, with a potential value of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,244.28 delivery order is for the supply of Testosterone Cypionate 200 mg/mL. The contract is not set aside and has a period of performance through June 27, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
- This federal contract award, valued at $1,416.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Testosterone Cypionate 200 mg/mL, a testosterone replacement therapy medication. The contract has an ultimate completion date of March 7, 2025 and uses a Firm Fixed Price pricing type. It is not designated with a set-aside requirement, indicating...
- This contract award, valued at $1,943.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The contract is for the delivery of Testosterone Cypionate 200 mg/mL, a pharmaceutical product, to support DLA Troop Support Medical operations. The contract is a firm-fixed price delivery order with a period of performance extending through August 9, 2023. This award is not associated with a set-aside program, indicating open...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA). The $1,839.98 firm-fixed-price contract is for the delivery of Testosterone Cypionate 200 mg/mL, a medication used for treating conditions related to testosterone deficiency. The contract has an ultimate completion date of June 6, 2025 and is not set aside for any particular type of business. Amerisourcebergen Drug Corp holds a significant...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA7H2Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,280.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Testosterone Cypionate 200 mg/mL medication. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 3/14/24 |